“Florida Gov. Ron DeSantis (R) is calling on regulators to allow use of two monoclonal antibody therapies for Covid-19 after the FDA halted their use in a ruling neither manufacturer disputes,” Bloomberg reports.
“The FDA said Monday that it was rescinding authorization for the use of Eli Lilly & Co. and Regeneron Pharmaceuticals Inc. monoclonal antibody treatments in the U.S. because they aren’t effective against omicron, which has become overwhelmingly dominant in all regions of the country, including Florida.”
Save to Favorites